Advisory Services Network’s Insight Molecular Diagnostics IMDX Stock Holding History

Advisory Services Network’s Portfolio IMDX Stock Details IMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,100	Closed	-$10.2K	–	3835
2026 Q1	$10.2K	Buy	+3,100	New	+$18K	﹤0.01%	3551

Other funds holding IMDX

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

FOR

Family Office Research Bethesda, Maryland $267M AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Advisory Services Network's IMDX Position: Q2 2026 in Review

Advisory Services Network sold out of Insight Molecular Diagnostics (IMDX) in Q2 2026, closing a stake of 3,100 shares — an estimated $10.2K sold.

Advisory Services Network first reported a position in IMDX in Q1 2026 and held it in 1 quarter. The position peaked at $10.2K in Q1 2026. 40 funds tracked by Wall St. Rank hold IMDX as of Q2 2026.

Advisory Services Network reported no remaining Insight Molecular Diagnostics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 3,100 Insight Molecular Diagnostics shares in Q2 2026, an estimated $10.2K.
Advisory Services Network first reported a position in Insight Molecular Diagnostics in Q1 2026 and held it in 1 quarter.
Advisory Services Network's Insight Molecular Diagnostics position peaked at $10.2K in Q1 2026.
40 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.